Noblesville, IN, United States of America

Mark Donald Chappell

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Noblesville, IN (US) (2005 - 2011)
  • Indianapolis, IN (US) (2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Inventor Behind 7 Patents: Mark Donald Chappell

Introduction: Mark Donald Chappell, a talented inventor based in Noblesville, IN, has made significant contributions to the field with 7 patents under his belt. Let's delve into his latest patents, career highlights, and collaborations.

Latest Patents: Mark's recent patents include innovative compounds such as 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists, which are mGlu2/3 receptor antagonists with various uses and preparation methods. Additionally, his work on glucagon receptor antagonists and their therapeutic uses showcases his expertise in developing novel pharmaceutical compounds for metabolic disorders.

Career Highlights: Mark Donald Chappell has lent his inventive skills to renowned companies such as Eli Lilly and Company, where he contributed to groundbreaking research and development projects. His tenure at the Sloan-Kettering Institute for Cancer Research further solidifies his reputation as a visionary in the field of pharmaceuticals.

Collaborations: Throughout his career, Mark has collaborated with esteemed professionals like Scott Eugene Conner and Guoxin Zhu, demonstrating his ability to work seamlessly within multidisciplinary teams to drive innovation and progress in the industry.

Conclusion: In conclusion, Mark Donald Chappell stands out as a dedicated inventor with a remarkable portfolio of patents, each highlighting his ingenuity and commitment to advancing scientific discoveries. His collaborations and career milestones underscore his influential presence in the pharmaceutical landscape, paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…